Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016)

Similar documents
Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015)

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2018)

Welcome to. April 4-5, DoubleTree by Hilton Hotel Silver Spring, MD USA

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2019)

14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017)

Welcome to. January 26, The Mayflower Hotel Washington, DC USA

Welcome to the CMC Strategy Forum Europe 2010: Challenges Facing Biopharmaceutical Development in the Next Decade

7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018)

12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)

Welcome to the CMC Strategy Forum Europe 2016

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. David Michels, Genentech, a Member of the Roche Group

8 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2019)

Welcome to the CMC Strategy Forum Europe 2015 Improving Biopharmaceutical Product Quality: Moving Implementation Forward

Welcome to the CMC Strategy Forum

Creating a global community of industry, regulatory and academic professionals to solve scientific and technical problems in order to advance the

7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018)

Symposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. Henry Luo, Regeneron Pharmaceuticals, Inc.

Welcome to the CMC Strategy Forum Europe 2016

Welcome to. January 27, Renaissance Mayflower Hotel Washington, DC USA

Northeast Regional Forum

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

Welcome to CMC Strategy Forum Japan 2015

Welcome to CMC Strategy Forum Japan 2017

Welcome to December Hotel Okura Tokyo, Japan

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015)

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing

Welcome to the CMC Strategy Forum

Welcome to the CMC Strategy Forum Europe 2018

Welcome to the CMC Strategy Forum Europe 2017

This is not unique to CE. It took for instance about 25 years for HPLC to establish itself properly in the pharmaceutical industry.

Welcome to the CMC Strategy Forum Europe 2018

PRELIMINARY PROGRAM Bay Area Discussion Group

Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009

MODULE 3 Preclinical safety May 2016 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES

The 24 th Autumn Introductory Course: Target the Heart of European Regulatory Affairs *Preliminary Programme

High Potent Medicines Conference

The 23 rd Autumn Introductory Course:

High Potent Medicines Conference

CMC Strategy Forum Prague Enda Moran EBE Satellite Session, 06 May 2013

Welcome to the CMC Strategy Forum

PRELIMINARY PROGRAM. Midwest Discussion Group. Co-chairs: James Carroll, Pfizer, Inc. Kathy Lee, Eli Lilly and Company

Regulatory Information Management

SPONSORSHIP OPPORTUNITIES

AGENDA Scientist Mentoring & Diversity Program [SMDP Biotech]

CE as an analytical tool in industrial biotechnology. David Goodall, CSO, Paraytec Ltd. 14 November Act P x

Sponsorship Opportunities FEFCO Technical Seminar

Welcome to the CMC Strategy Forum

CLINICAL TRIALS IN RUSSIA

MODULE 11 Pharmacovigilance March 2017 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES

Sponsorship & Branding opportunities

Welcome to the CMC Strategy Forum Latin America 2015

SHORT COURSE. Practical Considerations for Biomarker Bioanalysis: Scientific and Regulatory Perspective SUNDAY, SEPTEMBER 17

Innovation for Pharma to engage with the mobile user.

CASSS CMC Strategy Forum Barcelona, Spain. EBE Satellite Session Comparability Concept Paper 21 st March 2011

14 th GLOBAL CORPORATE ACTIONS FORUM

Connecting People, Science and Regulation

WELCOME COCKTAIL WITH LEGAL EXPERTS PRESENT AT THE 14 th MEDICINES FOR EUROPE LEGAL CONFERENCE REGISTRATION AND WELCOME COFFEE

Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions

Welcome to the WCBP CMC Strategy Forum

ESTIV Second circular and call for abstracts. The 18 th International Congress on In Vitro Toxicology ESTIV2014.

CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

9th Open EIP Scientific Symposium. And. Final ABIRISK Open conference. Immunogenicity of Biopharmaceuticals. Draft Program November 2017

Northern California Regional Forum

Modern Approaches to Process Understanding

BDA WORKSHOP PROGRAMME. HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS December 2013 BRUSSELS, BELGIUM

Pharmacopoeia 2019 PDA EUROPE. The 2 nd Annual PDA Conference on International Developments in the Pharmacopoeial Landscape PEOPLE SCIENCE AND

EXHIBITION AND SPONSORSHIP

Wednesday, June 13. 7:00 a.m. 5:30 p.m. Registration Open 7:00 a.m. 8:30 a.m. Continental Breakfast

Look for the conference agenda in January 2017 Conference Website: Registration: SPONSORSHIP OPPORTUNITIES

INTERNATIONAL CONFERENCE ON LONG-LIFE CONCRETE PAVEMENTS 2012

GLOBAL MARKETS AND MANUFACTURING TECHNOLOGIES FOR PROTEIN DRUGS

The State of QbD in the Biopharmaceutical Industry Conference

Welcome to CMC Strategy Forum Japan 2018

Plastics Caps and Closures 2019 Conference

GLOBAL CORPORATE ACTIONS FORUM

Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES

2015 Washington State Employment Law & HR Conference March 26-27, 2015 Meydenbauer Convention Center wastatecouncil.shrm.org

Sponsoring Opportunities

SPONSORSHIP OPPORTUNITIES

4.0 HEALTHCARE 4.0. The Data Imperative August 2018 Royal Randwick Turf Club, Sydney ANNUAL CONFERENCE MAJOR SPONSOR

The room was more than 3/4 full with greater than 150 people in attendance.

OPPORTUNITIES GUIDE and CONFERENCE PROSPECTUS. omen in Statistics and Data Science CINCINNATI, OHIO

SPONSORSHIP OPPORTUNITIES

Advanced Concepts for Change Control of Analytical Procedures with ICH Q12 Coming

DOP Annual Conference 2018

BENEFITS OF SPONSORSHIPS AT GLOBAL SOF FOUNDATION EVENTS:

FINAL PROGRAM. CASSS Bay Area Discussion Group. Co-chairs: Judy Chou, Medivation, Inc. Lance Wong, Strand Bio

Speakers Title & Biography

12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)

Calendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL

NATIONAL CONFERENCE ON THE SECURITIES INDUSTRY OCTOBER 11 12, 2017 NEW YORK LAW SCHOOL, NYC SPONSORSHIP OPPORTUNITIES

EXHIBITION & SPONSORSHIP PROSPECTUS DOCUMENT

U.S. Interchange SPONSORSHIP & EXHIBITOR GUIDE October 2018 Bethesda North Marriott Hotel & Conference Center Bethesda, MD

THERMAL MANAGEMENT SYSTEMS

BENEFITS OF SPONSORSHIPS AT GLOBAL SOF FOUNDATION EVENTS:

LSE Health Market Access Academy April 2018, London September 2018, London

MainTrain Ottawa 2018

Transcription:

Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016) Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto BV Hansjörg Toll, Sandoz GmbH 15-18 March, 2016 Imperial Riding School Renaissance Hotel Vienna, Austria Organized by

Table of Contents Program Partners, Exhibitors and Media Partners... Student Travel Grants... Social Program... Acknowledgements... Scientific Final Program Summary... Session Abstracts... Round Robin Table Description... Technical Seminar Abstract... Poster Abstracts... 2

The Organizing Committee gratefully acknowledges the following program partners for their generous support of this Symposium: Sustaining Platinum Program Partners AbbVie, Inc. MedImmune, A member of the AstraZeneca Group Sustaining Gold Program Partner Novo Nordisk A/S Platinum Program Partner Genedata GmbH Gold Program Partners Bruker Daltonik F. Hoffmann La Roche Ltd. Exhibitors Bruker Daltonik Genovis AB Waters Corporation 3

The Scientific Organizing Committee gratefully acknowledges the following media for their promotional consideration of AT Europe 2016: Media Program Partners Analyst Analytical Methods The Analytical Scientist BioProcess International International Pharmaceutical Quality The Medicine Maker The Pathologist separationsnow.com Technology Networks 4

CASSS AT Europe Student Travel Grants CASSS is pleased to provide a limited number of student travel grants for PhD students and post-docs who present applicable posters at the inaugural Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016). PhD students or post-doctoral fellows conducting research at academia throughout the world are eligible. Why you should apply: This Symposium is an active forum for discussion of recent developments and regulatory considerations of the practical application of analytical technologies amongst industry, academia and regulatory agencies. There will be a focus on capillary electrophoresis, mass spectrometry and chromatography for product characterization, process monitoring, formulation development and release testing in the biopharmaceutical industry. As a participant, you will have an excellent opportunity to meet, network and participate in exchanging knowledge for mutual education with your peers. Requirements are: - Present a poster on a MS, CE, LC topics relating to Biopharmaceuticals - Proof of studentship/post-doc status - Recommendation from your supervisor Deadline for submissions is Friday, December 18. 5

Social Program Wednesday, 16 March 18:00 19:00 Exhibition Reception Come network and visit exhibitors in the Linke Pirouette Room. Thursday, 17 March 19:00 22:00 Conference Event This event is open to all full conference attendees. One day only attendees will be charged extra to attend. Please see the registration desk for pricing. Location TBD. 6

Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto BV Hansjörg Toll, Sandoz GmbH Acknowledgements Scientific Program Committee: Martin Blüggel, Protagen Protein Services GmbH François de l Escaille, Analis s.a./n.v. Christof Finkler, F.Hoffmann La Roche Ltd. Marta Germano, Janssen Infectious Diseases and Vaccines András Guttman, Northeastern University Anders Lund, Genzyme, a Sanofi Company Birgit Schmauser, BfArM, Federal Institute for Drugs and Medical Devices Jeremy Springall, MedImmune, A member of the AstraZeneca Group Harold Taylor, Merz Pharmaceuticals GmbH Audio-Visual: Michael Johnstone, MJ Audio-Visual Productions CASSS Staff: Stephanie Flores, Executive Director Renee Olson, Senior Program Manager Anna Lingel, Project Coordinator Catherine Stewart, Finance Manager 7

AT Europe 2016 Scientific Final Program Summary Tuesday, 15 March, 2016 08:30 14:00 Registration (for course attendees ONLY) in the Foyer Reitschule 09:00 12:30 Short Course in Haute Ecole Room Fundamentals of Mass Spectrometry in the Analysis of Protein Therapeutics Short Course Facilitator: Anders Lund, Genzyme, a Sanofi Company, Framingham, MA USA 09:00 17:00 Short Course in Kleine Reitschule Room Reliable Methods in Capillary Electrophoresis: Fundamentals and Good Working Practice Short Course Facilitators: François de l'escaille, Analis s.a./n.v., Namur, Belgium and Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands 12:30 13:30 Hosted Lunch (for course attendees ONLY) in the Borromäus Restaurant 13:30 17:00 Short Course in Haute Ecole Room Applications of Mass Spectrometry to Characterize Protein Therapeutics Short Course Facilitator: Anders Lund, Genzyme, a Sanofi Company, Framingham, MA USA 8

08:30 18:00 Registration in the Foyer Wednesday, 16 March, 2016 09:00 09:15 Welcome and Introductory Comments in Rechte Pirouette Room Hansjörg Toll, Sandoz GmbH, Kundl, Austria Keynote I Session in Rechte Pirouette Room Session Chair: Hansjörg Toll, Sandoz GmbH, Kundl, Austria 09:15 10:15 Biosimilar Development and the Role of Analytical Technologies Martin Schiestl, Sandoz GmbH, Kundl, Austria 10:15 10:45 Break Visit the Exhibits and Posters the Linke Pirouette Room Process and Product Characterization Session in Rechte Pirouette Room Session Chairs: François de L Escaille, Analis SA, Suarlee, Belgium and Marta Germano, Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands 10:45 11:10 mab Characterization by Mass Spectrometry: from Routine Comparability/Stability Studies to Structural Investigation Francois Debaene, Sanofi-aventis, Vitry-sur-Seine, France 11:10 11:35 TBD Christian Huber, University of Salzburg, Salzburg, Austria 11:35 12:00 TBD 12:00 12:30 Discussion 12:30 13:30 Buffet Lunch in Borromäus Restaurant 13:30 15:00 Poster Session in the Linke Pirouette Room New Trends Analytical Technologies in Rechte Pirouette Room Session Chairs: Martin Blüggel, Protagen Protein Services GmbH, Dortmund, Germany and Harold Taylor, Merz Pharmacuticals GmbH, Frankfurt Am Main, Germany 15:00 15:25 Analytical Approaches to Understanding of Therapeutic Protein Quality Attributes in vivo Yelena Lyubarskaya, Biogen, Cambridge, MA USA 15:25 15:50 TBD Guinevere Kammeijer, Leiden University Medical Center 15:50 16:15 TBD 16:15 16:45 Discussion 9

16:45 17:00 Mini Break 17:00 18:00 Technical Seminar Wednesday, 16 March, 2016 Sponsored by Bruker Daltonik Rechte Pirouette Room 18:00 19:00 Exhibition Reception Visit the Linke Pirouettee Room 10

Thursday, 17 March, 2016 08:30 17:00 Registration in the Salon Foyer Quality by Design Innovative Method Development Session in Rechte Pirouette Room Session Chairs: Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands and Jeremy Springall, MedImmune, A member of the AstraZeneca Group, Cambridge, United Kingdom 09:00 09:25 TBD Melissa Hanna-Brown, Pfizer, Inc., Sandwich, United Kingdom 09:25 09:50 Designing Quality: Quality by Design in Analytical Pharmaceutical Development Luca Nompari, GlaxoSmithKline, Siena, Italy 09:50 10:15 Benefits of Applying QbD Concepts to Analytical Methods for Therapeutic Proteins - Case Studies Annick Gervais, UCB Pharma SA, Braine l Alleud, Belgium 10:15 10:45 Discussion 10:45 11:15 Break Visit the Exhibits and Posters in the Linke Pirouette Room 11:15 12:15 Roundtable Discussions Topics TBD Rechte Pirouette Room 12:15 13:15 Buffet Lunch in Borromäus Restaurant Analytical Technologies in the QC Environment Session in Rechte Pirouette Room Session Chair: Anders Lund, Genzyme, a Sanofi Company, Framingham, MA USA 13:15 13:40 TBD Crina Balog, Janssen Infectious Diseases and Vaccines 13:40 14:05 TBD 14:05 14:30 TBD 14:30 15:00 Discussion 15:00 15:30 Technical Seminar Sponsored by Genedata GmbH Rechte Pirouette Room 11

Thursday, 17 March, 2016 15:30 16:00 Break Visit the Exhibits and Posters in the Linke Pirouette Room 16:00 16:25 TBD 16:25 16:50 TBD Higher Order Structure Session in Rechte Pirouette Room Session Chair: Andras Guttman, Northeastern University, Boston, MA USA 16:50 17:20 Discussion 17:20 18:20 Technical Seminar Sponsored by Waters Corporation Rechte Pirouette Room 19:00 22:00 Conference Event Location TBD 12

Friday, 18 March, 2016 08:30 12:00 Registration in the Salon Foyer Analysis of Aggregates Session in Rechte Pirouette Room Session Chair: Christof Finkler, F. Hoffmann-La Roche Ltd., Basel, Switzerland and Marta Germano, Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands 09:00 09:25 Vaccine Product Characterization by AF4-MALS: Particle Size Distribution and Aggregation Martijn Schenning, Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands 09:25 09:50 Impact of Non-Ideal Analyte Behavior on Separation of Proteins and Aggregates by AF4 Atana Koulov, F. Hoffmann La Roche Ltd., Basel, Switzerland 09:50 10:20 Discussion 10:20 10:50 Break - Visit the Exhibits and Posters in the Linke Pirouette Room Regulatory Session in Rechte Pirouette Room Session Chair: Birgit Schmauser, BfArM, Federal Institute for Drugs and Medical Devices, Cologne, Germany 10:50 11:15 Examples of Regulatory Expectations for Analytical Characterization and Testing Vicky Venizelos, Consultant 11:15 11:40 Applications of Mass Spectrometry to Streamline Product Characterization, Release and Stability Testing Juhong Liu, CDER, FDA, Silver Spring, MD USA 11:40 12:05 Expectations for Analytical Characterization in the Evaluation of Biosimilarity: A Regulator s Perspective Christian Mayer, Austrian Medicines and Medical Devices Agency, Vienna, Austria 12:05 12:35 Discussion 12:35 12:40 Closing Comments in Rechte Pirouette Room Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands 13